SVQ Sinovac Biotech Ltd.

The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Sinovac Biotech Ltd

NEW YORK--(BUSINESS WIRE)--

The Klein Law Firm announces the commencement of an investigation of Sinovac Biotech Ltd (NASDAQ: SVA) concerning possible violations of federal securities laws.

On December 21, 2016, an article published by SeekingAlpha.com revealed that Sinovac's Chairman and Chief Executive Officer, Weidong Yin, paid bribes to the Deputy Director General of the Center for Drug Evaluation for the China Food and Drug Administration and his wife, to help advance drug applications and evaluations. Sinovac later announced on May 16, 2017 that the Securities Exchange Commission is investigating the Company for alleged bribery mentioned in SeekingAlpha's article, and that Sinovac would not be able to file its annual financial results on time.

If you suffered a loss in Sinovac and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kkclasslaw.com/SVA-Info-Request-Form-172.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
12/07/2017

Underlying

SVQSinovac Biotech Ltd.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sinovac Biotech Ltd.

 PRESS RELEASE
Free
SVQ Sinovac Biotech...

September 1st Deadline Alert: The Law Offices of Howard G. Smith Remin...

BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith reminds investors of the September 1, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA) securities between April 30, 2013 to May 16, 2017, inclusive (the “Class Period”). Sinovac investors have until September 1, 2017 to file a lead plaintiff motion. Investors suffering losses on their Sinovac investments are encouraged to conta...

August 30, 2017 1 EN
 PRESS RELEASE
Free
SVQ Sinovac Biotech...

The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf...

NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd. (NASDAQ:SVA) who purchased shares between April 30, 2013 and May 16, 2017. The action, which was filed in District of New Jersey, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) Defendant Weidong Yin,...

July 21, 2017 1 EN
 PRESS RELEASE
Free
SVQ Sinovac Biotech...

The Klein Law Firm Announces a Class Action Filed on Behalf of Sinovac...

NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd. (NASDAQ: SVA) who purchased shares between April 30, 2013 and May 16, 2017. The action, which was filed in District of New Jersey, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) Defendant Weid...

July 20, 2017 1 EN
 PRESS RELEASE
Free
SVQ Sinovac Biotech...

SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors ...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ:SVA) securities between April 30, 2013 and May 16, 2017. Click here to learn about the case: http://www.wongesq.com/pslra-sb/sinovac-biotech-ltd?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Company issued materially fal...

July 19, 2017 1 EN
 PRESS RELEASE
Free
SVQ Sinovac Biotech...

SVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Invest...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ:SVA) securities between April 30, 2013 and May 16, 2017. Click here to learn about the case: http://www.wongesq.com/pslra-sb/sinovac-biotech-ltd?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Company issued materially fal...

July 18, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch